• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素 -(1 - 7)通过Mas受体在体内刺激大鼠心外组织中Akt的磷酸化。

Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

作者信息

Muñoz Marina C, Giani Jorge F, Dominici Fernando P

机构信息

Instituto de Química y Fisicoquímica Biológicas , Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.

出版信息

Regul Pept. 2010 Apr 9;161(1-3):1-7. doi: 10.1016/j.regpep.2010.02.001. Epub 2010 Feb 25.

DOI:10.1016/j.regpep.2010.02.001
PMID:20188769
Abstract

The in vivo effect of angiotensin (ANG)-(1-7) on the activation of insulin signaling transduction in rat extracardiac tissues is unknown. Thus, in the present study, we evaluated the ability of ANG-(1-7) to stimulate the phosphorylation of Akt, a main mediator of insulin action in rat extracardiac tissues (adipose tissue, liver and skeletal muscle). We proved that ANG-(1-7) induces the phosphorylation of Akt at both threonine 308 and serine 473 in all tissues analyzed. Selective antagonism of the Mas receptor with A779 blocked the ANG-(1-7)-induced Akt phosphorylation in extracardiac tissues. Reinforcing this evidence, we determined that ANG-(1-7) induces the in vivo activation of the downstream target of Akt, glycogen synthase kinase-3beta in liver and skeletal muscle. Moreover, in every tissue analyzed, the presence of the Mas receptor was detected by immunohistochemical analysis. Based on the current results, we postulate that ANG-(1-7) could be a positive physiological contributor to the actions of insulin in extracardiac tissues. Therefore, our findings extend the possibilities for new approaches in the study of ANG-(1-7)/Mas receptor axis and show the therapeutic potential of ANG-(1-7) in the treatment of metabolic disorders such as insulin resistance as well as other disorders associated with diminished Akt activity.

摘要

血管紧张素(ANG)-(1-7)对大鼠心外组织中胰岛素信号转导激活的体内作用尚不清楚。因此,在本研究中,我们评估了ANG-(1-7)刺激Akt磷酸化的能力,Akt是大鼠心外组织(脂肪组织、肝脏和骨骼肌)中胰岛素作用的主要介质。我们证明,ANG-(1-7)在所有分析的组织中均能诱导苏氨酸308和丝氨酸473位点的Akt磷酸化。用A779对Mas受体进行选择性拮抗可阻断心外组织中ANG-(1-7)诱导的Akt磷酸化。进一步证实这一证据的是,我们确定ANG-(1-7)可诱导肝脏和骨骼肌中Akt的下游靶点糖原合酶激酶-3β的体内激活。此外,通过免疫组织化学分析在每个分析的组织中检测到了Mas受体的存在。基于目前的结果,我们推测ANG-(1-7)可能是心外组织中胰岛素作用的一种正向生理促进因子。因此,我们的研究结果扩展了ANG-(1-7)/Mas受体轴研究新方法的可能性,并显示了ANG-(1-7)在治疗代谢紊乱(如胰岛素抵抗)以及其他与Akt活性降低相关疾病方面的治疗潜力。

相似文献

1
Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.血管紧张素 -(1 - 7)通过Mas受体在体内刺激大鼠心外组织中Akt的磷酸化。
Regul Pept. 2010 Apr 9;161(1-3):1-7. doi: 10.1016/j.regpep.2010.02.001. Epub 2010 Feb 25.
2
The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).Mas受体介导血管紧张素-(1-7)对胰岛素信号传导的调节。
Regul Pept. 2012 Aug 20;177(1-3):1-11. doi: 10.1016/j.regpep.2012.04.001. Epub 2012 May 1.
3
ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.血管紧张素(1-7)通过一种 Mas 受体依赖的机制增强 Akt 磷酸化,从而减少血管紧张素 II 诱导的大鼠骨骼肌胰岛素抵抗。
Biochem Biophys Res Commun. 2012 Sep 28;426(3):369-73. doi: 10.1016/j.bbrc.2012.08.093. Epub 2012 Aug 28.
4
Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.血管紧张素 -(1 - 7)在体内刺激大鼠心脏中JAK2、IRS - 1和Akt的磷酸化:AT1和Mas受体的作用。
Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1154-63. doi: 10.1152/ajpheart.01395.2006. Epub 2007 May 11.
5
Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.血管紧张素-(1-7) 通过 mas 受体募集肌肉微血管,并增强胰岛素的代谢作用。
Hypertension. 2014 Jun;63(6):1219-27. doi: 10.1161/HYPERTENSIONAHA.113.03025. Epub 2014 Apr 7.
6
Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.转化生长因子-β抑制成纤维细胞中 Mas 受体的表达,但不抑制成肌细胞或分化的肌管中 Mas 受体的表达;与肌肉疾病相关的纤维化的相关性。
Biofactors. 2015 Mar-Apr;41(2):111-20. doi: 10.1002/biof.1208. Epub 2015 Mar 23.
7
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.血管紧张素 -(1 - 7)通过一种依赖Mas受体的机制减轻血管紧张素II诱导的骨骼肌萎缩。
Clin Sci (Lond). 2015 Mar;128(5):307-19. doi: 10.1042/CS20140215.
8
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.血管紧张素 -(1 - 7)通过其受体Mas减轻小鼠废用性骨骼肌萎缩。
Dis Model Mech. 2016 Apr;9(4):441-9. doi: 10.1242/dmm.023390. Epub 2016 Feb 5.
9
Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.血管紧张素 -(1 - 7)抑制血管紧张素II刺激的近端肾小管细胞中丝裂原活化蛋白激酶的磷酸化。
Kidney Int. 2006 Jun;69(12):2212-8. doi: 10.1038/sj.ki.5001509. Epub 2006 May 3.
10
The ACE2-angiotensin-(1-7)-Mas axis protects against pancreatic cell damage in cell culture.ACE2-血管紧张素-(1-7)-Mas轴在细胞培养中可保护胰腺细胞免受损伤。
Pancreas. 2015 Mar;44(2):266-72. doi: 10.1097/MPA.0000000000000247.

引用本文的文献

1
Molecular dissection of the role of ACE2 in glucose homeostasis.血管紧张素转换酶2(ACE2)在葡萄糖稳态中作用的分子剖析
Physiol Rev. 2025 Jul 1;105(3):935-973. doi: 10.1152/physrev.00027.2024. Epub 2025 Feb 7.
2
Phosphoproteomics for studying signaling pathways evoked by hormones of the renin-angiotensin system: A source of untapped potential.用于研究肾素-血管紧张素系统激素引发的信号通路的磷酸化蛋白质组学:一个尚未开发的潜在来源。
Acta Physiol (Oxf). 2025 Feb;241(2):e14280. doi: 10.1111/apha.14280.
3
Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review.
靶向肾素-血管紧张素系统的保护分支以改善胰岛素敏感性的治疗机会:一项机制综述
Hypertens Res. 2024 Dec;47(12):3397-3408. doi: 10.1038/s41440-024-01909-y. Epub 2024 Oct 3.
4
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.Mas 受体:缺血性心血管疾病治疗的潜在策略。
Cell Cycle. 2023 Jul;22(13):1654-1674. doi: 10.1080/15384101.2023.2228089. Epub 2023 Jun 26.
5
Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.从肾素-血管紧张素-醛固酮系统角度理解糖尿病性心肌病。
Pflugers Arch. 2022 Jan;474(1):63-81. doi: 10.1007/s00424-021-02651-x. Epub 2021 Dec 30.
6
Interactions between diabetes and COVID-19: A narrative review.糖尿病与2019冠状病毒病的相互作用:一篇叙述性综述。
World J Diabetes. 2021 Oct 15;12(10):1674-1692. doi: 10.4239/wjd.v12.i10.1674.
7
Renin-Angiotensin-Aldosterone System and Immunomodulation: A State-of-the-Art Review.肾素-血管紧张素-醛固酮系统与免疫调节:最新综述。
Cells. 2021 Jul 13;10(7):1767. doi: 10.3390/cells10071767.
8
2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus.2020年小儿肾脏疾病中肾素-血管紧张素-醛固酮系统及其与冠状病毒相互作用的最新进展
Pediatr Nephrol. 2021 Jun;36(6):1407-1426. doi: 10.1007/s00467-020-04759-1. Epub 2020 Sep 29.
9
Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system.两种有氧运动方案可调节肾素-血管紧张素系统的反调节轴。
Heliyon. 2020 Jan 16;6(1):e03208. doi: 10.1016/j.heliyon.2020.e03208. eCollection 2020 Jan.
10
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.有氧运动训练可预防肥胖和胰岛素抵抗,而与皮下白色脂肪组织中肾素血管紧张素系统的调节无关。
PLoS One. 2019 Apr 25;14(4):e0215896. doi: 10.1371/journal.pone.0215896. eCollection 2019.